4-(3-(4-fluoroisoindolin-2-yl)-3-methylbutyl)-2-isopropoxyphenol

ID: ALA4867297

PubChem CID: 91826734

Max Phase: Preclinical

Molecular Formula: C22H28FNO2

Molecular Weight: 357.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)Oc1cc(CCC(C)(C)N2Cc3cccc(F)c3C2)ccc1O

Standard InChI:  InChI=1S/C22H28FNO2/c1-15(2)26-21-12-16(8-9-20(21)25)10-11-22(3,4)24-13-17-6-5-7-19(23)18(17)14-24/h5-9,12,15,25H,10-11,13-14H2,1-4H3

Standard InChI Key:  CZMKZNSLFDBBJT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    8.4319  -18.7624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0275  -18.0566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6185  -18.7598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4890  -16.8349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4879  -17.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1959  -18.0634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9056  -17.6540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9027  -16.8313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1941  -16.4261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7812  -16.4265    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6139  -18.0615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3210  -17.6518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7364  -17.6495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7798  -18.0625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7792  -18.8797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0712  -19.2877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4866  -19.2888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4799  -17.9808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8212  -16.8338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6212  -16.6656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0264  -17.3748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8413  -17.3774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2520  -16.6717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8418  -15.9618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0282  -15.9626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2476  -18.0865    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  4 10  1  0
  7 11  1  0
 11 12  1  0
 12  2  1  0
  2 13  1  0
  5 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 13 18  1  0
 18 21  1  0
 20 19  1  0
 19 13  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 22 26  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

TMEM97 Tchem Sigma intracellular receptor 2 (973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

N2a (708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 357.47Molecular Weight (Monoisotopic): 357.2104AlogP: 5.05#Rotatable Bonds: 6
Polar Surface Area: 32.70Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.26CX Basic pKa: 7.77CX LogP: 5.28CX LogD: 4.75
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.79Np Likeness Score: -0.45

References

1. Rishton GM, Look GC, Ni ZJ, Zhang J, Wang Y, Huang Y, Wu X, Izzo NJ, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Catalano SM..  (2021)  Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease.,  12  (9.0): [PMID:34531947] [10.1021/acsmedchemlett.1c00048]

Source